Podcasts about Leukemia

Peter McLaughlin was given a twin diagnosis 23 years ago: Lyme disease and leukemia on the same day. The doctors told him if he was lucky, he had 10 years. They didn't know what caused it and they didn't know how to cure it. So he went looking himself. What he found in the depths of his own psyche became the foundation of an entire life's work in hypnotherapy, past life regression, Havening, and subconscious reprogramming. He's been healthy for 23 years. And in this conversation, he shares what he learned along the way, including one of the most fascinating explanations I've ever heard for why we drink. We get into what hypnosis actually is and why the entertainment version of it has given most people completely the wrong idea. We talk about how trauma gets encoded in the nervous system as safe or not safe, and why that single distinction explains almost every self-sabotaging pattern people can't seem to break. We go into past life regression, what happens emotionally when someone encounters a lifetime they consciously have no memory of.  And we talk about alcohol. Specifically, why it's called spirits. What it actually does energetically when you drink. And how Peter uses future progression in hypnosis to help people feel, in their body, the 10-year contrast between two versions of their life, one that keeps drinking and one that doesn't.   IN THIS EPISODE  The twin diagnosis that sent Peter into the depths of his own subconscious, and what he found there What hypnosis actually is, why the entertainment version gets it completely wrong, and the everyday experience almost everyone has had that is genuinely hypnotic Why alcohol is called spirits, and what Peter believes is actually happening energetically when you drink How root cause healing differs from symptom management, and why going back to the origin of a pattern is the only thing that actually resolves it Past life regression: what it feels like from the inside, what happens emotionally, and why the most mundane past lives are often the most moving Havening: what it is, how it works, and why the magic isn't in the tapping The future progression technique Peter uses with clients, and why the 10-year contrast is so powerful Why other people don't give you love, they just trigger the feelings you're already capable of generating yourself The one book Peter recommends above all others, and why he reread it after his father died   Find Peter at blueskyhypnosis.com and on YouTube at Blue Sky Hypnosis, where his past life regression track has nearly a million views. Join over 20,000 souls who tune into weekly newsletters on the competitive advantage you get alcohol-free. Get on the Euphoric newsletter. Apply to be our next Thought Leader to master premium selling and thought leader positioning to publish your book and deliver your keynote onstage.  Euphoric the Club is the premier space to lose the desire for alcohol as you surround yourself with successful women who don't drink (and the women who are becoming them). Euphoric the Club includes full access to all of my alcohol-free programs to make alcohol meaningless as your dreams take center stage, meaningful monthly challenges, weekly coaching and more.  If you know you're meant to help other people change their relationship with alcohol and create a profitable online brand, be sure to get on the waitlist for the Empowered AF Coach 5x Certification – and get 5x certified as a world class alcohol-free empowerment coach, subconscious change coach, success coach, NLP practitioner, and hypnosis practitioner and implement our 0 to $100k Coach Method™ as your build a profitable brand.  Profiling successful people who don't drink and where the alcohol-free lifestyle and entrepreneurship collide. Subscribe to the Euphoric AF YouTube channel. Read Euphoric: my HarperCollins bestseller on losing the desire for alcohol while getting high on your dream life. Be sure to get your copy of Euphoric: Ditch Alcohol and Gain a Happier, More Confident You today or grab your free chapter here.  Follow @euphoric.af on Instagram.  Please do rate, review, and subscribe so we can continue spreading our message far and wide!

In this week's episode, Blood editor Dr. James Griffin interviews Drs. George Goshua, Gerd Blobel, and Paul Kaminski on their latest articles published in Blood. Dr. Goshua elaborates on the background and then insights from "Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis". This analysis provides valuable guidance for clinicians, patients, and health systems as they consider treatment choices. However, as concluded in the accompanying Blood Commentary, the true measure of success is not which therapy “wins” the economic argument, but whether each patient receives the therapy best suited to their clinical needs and values. Then, Drs. Gerd Blobel and Paul Kaminski share "Dissecting polycomb complexes for enhanced fetal hemoglobin production", which utilizes a comprehensive CRISPR-based screen to interrogate the components of these repressive complexes and identified a single protein domain in EZH2, a subunit of PRC2, as a potential therapeutic target. They demonstrate that inhibition of the domain encoded by exon 14 of EZH2 selectively derepresses fetal hemoglobin expression, raising the possibility of developing drugs that specifically target this domain to treat hemoglobinopathies.

Some of the most serious diagnoses in pediatrics begin with common pediatric symptoms. A child comes in looking pale or with a febrile illness. They've been more tired than usual. Maybe they're bruising easily or complaining their legs hurt. Individually, none of these symptoms are unusual. Together, or with persistence, they can tell a different story. Leukemia is the most common childhood cancer, but it's earliest signs often resemble everyday illnesses.   The episode introduces Ashley Rogers, MD, a pediatric oncologist at Children's Hospital Colorado and faculty member at the University of Colorado School of Medicine, as the newest host of Charting Pediatrics. As David Brumbaugh concludes his remarkable nine-year tenure as host, he passes the microphone to Dr. Rogers, ushering in the next chapter of the podcast.  Dr. Rogers joins the conversation to share her expertise on childhood leukemia, including key considerations for diagnosis, treatment and the pediatrician's role in recognizing and managing these patients. This episode offers both valuable clinical insights and a warm welcome to a new voice who will continue bringing evidence-based pediatric education to listeners.  Some highlights from this episode include: Earliest signs of leukemia pediatricians can look out for  How to distinguish between viral illnesses or leukemia  Red flags that shouldn't be dismissed  Role of the pediatrician after a leukemia diagnosis   For more information on Children's Colorado, visit: childrenscolorado.org. 

Positive test, negative test, same day, 4 hours apart. WTFFFFFFFFFF IS GOING ONNNNNNNNNNNNNN. AHHHHHHHHHHHH Also 7th Valkyrie news —--------------------- Want more 7th Valkyrie? Check out our Patreon to become a Hero of Edara, where you can shape the future of the series, decide on merch drops and incentives, get early access to new episodes, enjoy bonus features and content, and help us hit the major checkpoints on the Path of Heroes!  https://www.patreon.com/7thvalkyrie  

Send us Fan MailMorning Prayer (Our Eyes Look To The LORD; Forgiveness; Leukemia / Blood disorders; Freedom From Pain; Leaders to Serve Lord; Praise)Thank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peaceaimingforjesus.comYouTube Channel https://www.youtube.com/@aimingforjesus5346Instagram https://www.instagram.com/aiming_for_jesus/Threads https://www.threads.com/@aiming_for_jesusX https://x.com/AimingForJesusTik Tok https://www.tiktok.com/@aiming.for.jesus

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Matthew Frank and Jieqing Zhu on their latest articles published in volume 147 issue 22 of Blood. Dr. Frank discusses "How I treat HLH-like toxicities after immune effector cell therapy", in which the two cases presented emphasize the need for early identification, the use of anticytokine therapy with either emapalumab or ruxolitinib when organ toxicities worsen despite conventional CRS-directed treatment, and the need for ancillary supportive care as central to success. Dr. Zhu shares insights from "Structural Basis of HPA-1 a Alloimmunization in FNAIT and Allosteric Regulation of Integrin Conformation" where they probed the structure-function relationships underpinning interactions of alloantibodies against the most common target, human platelet antigen 1a (HPA-1a). Their data can help explain why some alloantibodies cause severe hemorrhagic FNAIT while others result in milder, asymptomatic thrombocytopenia.

What happens when your life changes overnight with a diagnosis that seems impossible to overcome?On this episode of This Week in America with Ric Bratton, author Janet McDowell shares the remarkable true story behind her memoir, Chasing a Light in the Darkness: A Story of Resilience in the Face of Unrelenting Medical Challenges.Shortly after her 61st birthday, Janet was diagnosed with lymphocytic leukemia—a disease often treatable in children but far more difficult for older adults. What followed was a years-long battle that included two near-death experiences, a stem cell transplant, serious rejection complications, and countless setbacks.Yet through every obstacle, Janet refused to surrender hope.In this deeply personal conversation, Janet discusses: Receiving a life-changing leukemia diagnosis Enduring life-threatening medical complications The emotional challenges of asking for help The vital role her sister Susan played as caregiver Finding hope during overwhelming uncertainty Lessons about resilience, courage, gratitude, and perseverance Whether you've faced illness yourself, cared for a loved one, or simply need encouragement during difficult times, Janet's story is a powerful reminder that hope can shine even in life's darkest moments.This Week in America with Ric Bratton is one of America's longest-running and most respected syndicated radio shows and podcasts, heard on more than 100 radio stations and podcast platforms worldwide. Each week, Ric brings listeners compelling conversations with bestselling authors, thought leaders, medical experts, business innovators, and extraordinary individuals whose stories educate, inspire, and entertain.If you're searching for inspiration through cancer recovery, leukemia survivor stories, medical memoirs, stem cell transplant experiences, caregiver support, resilience, hope, and overcoming life's greatest challenges, don't miss this moving conversation with Janet McDowell.https://www.jlmcdowell.comhttps://www.amazon.com/Chasing-Light-Darkness-resilience-unrelenting/dp/B0GFCX6X3Vhttps://mainspringbooks.comKeywordsJanet McDowell, Chasing a Light in the Darkness, leukemia survivor, lymphocytic leukemia, cancer survivor, cancer recovery, stem cell transplant, graft versus host disease, medical memoir, inspirational memoir, resilience, hope, perseverance, caregiver support, family caregiving, overcoming adversity, chronic illness, healing journey, cancer treatment, patient story, health podcast, inspirational author, memoir interview, medical challenges, surviving cancer, This Week in America, Ric Bratton, podcast interview, overcoming illness, hope after cancer

Click to Subscribe: https://bit.ly/Youtube-Subscribe-SoapDirt Days of our Lives spoilers bring a dramatic twist as Joy Wesley (AlexAnn Hopkins) faces a serious health scare, potentially altering the lives of Alex Kiriakis (Robert Scott Wilson) and Stephanie Johnson (Abigail Klein). Jeremy Horton (Trevor Donovan) continues to stir the pot in Salem, resulting in further tension between Joy, Stephanie, and Alex. As the situation unfolds, Stephanie's lack of understanding and empathy for Joy's predicament may exacerbate the situation further.  DOOL spoilers deliver an unexpected turn of events and hint at a devastating diagnosis for Joy, with Leukemia being a possible outcome. This could potentially reveal secrets surrounding the paternity of Kelsey and the alleged tampering of the paternity test. Alternatively, a twist could lead to a plot where Joy loses her battle with cancer, leaving her daughter Kelsey in the joint custody of Alex and Stephanie. This could strain Alex and Stephanie's already fragile marriage to its breaking point.  Spoilers for Days of our Lives anticipate that Belle Black (Martha Madison) attempts to mediate the escalating situation, but is met with resistance from Stephanie. Stephanie's interference in Alex's co-parenting challenges with Joy could further exacerbate the situation. This week, fans are in for a rollercoaster of emotions as Joy's health scare unfolds, potentially revealing hidden secrets and causing a rift in multiple relationships. Soap Dirt is the most subscribed to YouTube soap opera channel. Visit our Days of our Lives section of Soap Dirt: https://soapdirt.com/category/days-of-our-lives/ Listen to our Podcasts: https://soapdirt.podbean.com/ And Check out our always up-to-date Days of our Lives Spoilers page at: https://soapdirt.com/days-of-our-lives-spoilers/ Check Out our Social Media... Twitter: https://twitter.com/SoapDirtTV Facebook: https://www.facebook.com/SoapDirt Pinterest: https://www.pinterest.com/soapdirt/ TikTok: https://www.tiktok.com/@soapdirt Instagram: https://www.instagram.com/soapdirt/

Since it came up lately, here is, for the first time to the public, Dave being asked to try a food blindfolded. Also a bonus fact about why scientists can never get that last 0.1% of bacteriaDonate to Rebs' cycling fundraiser here for Leukemia & Lymphoma NI and Laurel House Chemo Unithttps://www.justgiving.com/crowdfunding/rebs-lightbodyNew full episodes every Thursday.Bonus mini-eps on Sundays and Tuesdays.To listen to Dave on the radio check outhttps://www.todayfm.com/shows/dave-moore-1499732 To see Neil on tour check outhttps://www.neildelamere.com/reinventing-the-neil-tourhttps://www.neildelamere.com/neils-on-wheels-tourYou can watch the podcast on Youtubehttps://www.youtube.com/@WhyWouldYouTellMeThatpodcastPresented and Produced by Neil Delamere and Dave MooreEdited by Diarmuid O'BrienMusic by Dave MooreArtwork by Ray McDonnell Hosted on Acast. See acast.com/privacy for more information.

It's Friday. It's Megadeth day. Let's f'ing GOOOOOOOO!!!! Yes, Megadeth & Obituary are at the La Crosse Center tonight and you can still get tickets at the door. Gates open at 5pm and music should start around 7pm. Don't miss Megadeth before they retire from touring FOREVER!!! On this show this morning, we played a bunch of Megadeth tunes to get pumped for the show tonight…and we gazed into the future at some things to look forward to in the month of August. Including movies, TV shows, sporting events, & holidays. Doc joined me just after 8am for this week's racing report thanks to County Materials in Holmen & Eau Claire. In the news this morning, a recall on rechargeable hand warmers, Mandela Barnes drops out of the WI Governor's race, a man gets 15 years in prison for supplying his son the gun used to kill two students & two teachers, the Army has been testing a new weapon with a badass name, In sports, the Brewers are in LA to take on the Angels tonight, more info on the Tony Romo DUI arrest, Deebo Samuel gets a contract extension, Lebron is going to be filming his entire season with the 76ers for an upcoming documentary, and UEFA is going to boycott all FIFA competitions. Let you know what's on TV & streaming this weekend along with what's new in theaters. Plus, Greg Brady joins the Smashing Pumpkins on-stage for a Brady Bunch classic. And a "Clueless" sequel is in the works with Alicia Silverstone on-board. Fantastic story about a postal worker who helped save a baby's life thanks to her years of medical training, and a young Leukemia patient is going viral for her unique decorations while in the hospital. Elsewhere in sports, Paige Bueckers & Angel Reese won't face any discipline from the WNBA over a friend wager made on video, one of the co-owners of the Seattle Storm gets in trouble with the league, the PGA is going to air an announcer-free stream of it's upcoming tournament, and a TOPPS Shohei Ohtani card just sold for a LOT of money. And in today's edition of "Bad News with Happy Music", we had stories about a three year-old kid who snuck out of his house & walked a half mile to grandma's, a naked man hiding in the ceiling of a plasma donation center, a kid who got suspended from school because he bit his sandwich into the shape of a gun, a #FloridaMan who admits it's him on video committing a crime, Aldi was trying to sell four ice cubes for $5, and a woman gets mad about her drive-thru wait at a KFC.See omnystudio.com/listener for privacy information.

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Pierre-Yves Dumas and Samik Basu on their latest articles published in Blood. Dr. Dumas talks about "Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy" where the team was able to identify that ultra-low-burden FLT3-ITD microclones are associated with higher relapse risk and inferior relapse-free survival. Their work encourages the evaluation of FLT3 inhibitor strategies. Dr. Basu discusses "CD19 CAR T-cell therapy is feasible for patients with pemphigus vulgaris treated without lymphodepletion in the RESET-PV trial". In four patients, the treatment was well tolerated and supported CAR T-cell expansion and persistence, challenging the need for lymphodepletion and supporting chemotherapy-free approaches in autoimmune disease.

In today's episode, we spoke with Jorge E. Cortes, MD, and Elias Jabbour, MD. Dr Cortes is the chief of Hematology in the Division of Hematology and Oncology and the associate director for Translation at the UAB O'Neal Cancer Center in Birmingham, Alabama. Dr Jabbour is a professor of leukemia in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston.In our exclusive interview, Dr Cortes and Dr Jabbour discussed the orally disintegrating tablet formulation of nilotinib (Cavhanza) and its recent June 2026 FDA approval for patients with chronic myeloid leukemia (CML). After diving into the approval itself and the data that supported it, they both discussed why the approval is significant and which patients it will benefit most. In addition to covering the approval, the two also shed light on what is to come for biosimilars and alternate formulations in the greater CML treatment paradigm.

What role does muscle strength play in healthy aging, longevity, and independence? In this episode, Dr. Gillian Lockitch speaks with Jeanne Phares about why maintaining and building muscle becomes increasingly important for women during and after menopause. Drawing on her personal experience as a leukemia survivor and decades of strength training, Jeanne explains the connections between muscle mass, metabolism, bone health, resilience, and recovery. Listeners will learn practical strategies for strength training, nutrition, and lifestyle habits that support vitality and healthspan at every age. Jeanne Phares is Founder of Sage Lifestyle Collective and creator of the Sage Strength Transformation Program. She is a Certified Health & Wellness Coach, Strength Trainer, and author specializing in women's health after 50. Prior to entering the health field, she enjoyed a successful career as a Certified Public Accountant and executive mentor. Her work focuses on strength training, nutrition, menopause education, and healthy aging for women. She helps women build muscle, improve metabolic health, and maintain independence throughout midlife and beyond. A leukemia survivor, she credits decades of strength training with helping her withstand intensive treatment and recovery.  Episode Timeline  00:00 – Welcome and introduction  03:00 – Why muscle strength predicts healthy aging and longevity  04:36 – Jeanne's journey from CPA to health and wellness coach  05:30 – Leukemia diagnosis and the role of physical resilience in recovery  09:30 – Stem cell transplant and rebuilding strength after illness  13:15 – Turning health challenges into opportunities for growth  15:46 – Common misconceptions about lifting weights after 50  18:35 – Why walking and yoga alone may not be enough  20:00 – Muscle health, bone strength, and menopause  23:53 – Strength training as the foundation of healthy aging  25:15 – Nutrition mistakes women commonly make after menopause  28:49 – Hydration, electrolytes, and healthy aging  30:23 – Whole foods nutrition and listening to your body  34:44 – The one simple change that supports lifelong health  36:23 – Final thoughts and key takeaways  Connect with Jeanne Phares Sage Lifestyle Collective  www.sagelifestylepress.com Free Gifts for Listeners: Each guest will receive all three: 1. Free Chapter Download: "Your Body Changed the Rules. Here's the New Playbook" from Eat for Strength for Women Over 50 2.Free Starter Guide: The Sage Strength Starter Guide 3.Lottery Entry: A chance to win one of 10 discount codes for the 8-Week Sage Strength Transformation Program or one of 10 free audiobooks of Eat for Strength for Women Over 50 Books: The Beginner's Guide to Strength Training for Women Over 50 Eat for Strength for Women Over 50  Sage Strength Transformation Program : Free strength training and healthy aging resources  Connect with Your Host: Dr. Gillian Lockitch Email: Askdrgill@gmail.com website: https://askdrgill.com  

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Hanny Al-Samkari and Xin Zhou on their latest articles published in Blood. This episode highlights two important advances in hematology: the first report from the CHORUS registry for hereditary hemorrhagic telangiectasia (HHT) presented by Dr. Al-Samkari and also the introduction of the ASH Hematomics (ASHOP) platform for integrative genomic data analysis presented by Dr. Zhou. The CHORUS registry reveals that HHT is a progressive, underrecognized inherited bleeding disorder with a substantial burden of recurrent bleeding, iron deficiency, arteriovenous malformations, and life-threatening complications, while emphasizing the need for earlier diagnosis and the development of targeted therapies. The second presentation introduces ASHOP, an open-access platform that enables researchers to explore and integrate large-scale clinical and genomic datasets, facilitating discoveries in leukemia and other hematologic diseases through advanced analytical tools. Together, these studies demonstrate how comprehensive patient registries and innovative data-sharing resources are advancing precision medicine, improving disease understanding, and accelerating future research across hematology.

Dr. Bob Martin joins Dr. Adam Brockman for a full hour of real answers to real questions — fromnavigating a chronic leukemia diagnosis and the nerve pain of transverse myelitis, to unmasking a viral "miracle" diabetes ad and making sure your supplements aren't secretly working against each other.Straight talk, real science, no gimmicks.

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Haris Sohail and Lucas Kühne on their latest articles published in volume 147 issue 21 of Blood. In this CME article titled, "Retrospective, Real-World Study of IV Iron Use to Treat Iron deficiency Anemia During Acute Infection",  Sohail et al show that IV iron given during acute infection with iron deficiency anemia is associated with improved 14-day and 90-day survival as well as hemoglobin recovery. Although this report has the limitations of a retrospective study, these findings challenge current practice and support randomized trials that include patients with infection. In "Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura", Kühne et al show in a multicenter registry study of 204 patients that refractoriness during caplacizumab treatment in immune TTP is uncommon and, when observed, is typically associated with confounding clinical factors. These findings underscore the importance of careful clinical reassessment and evaluation for alternative etiologies in patients with delayed platelet recovery, rather than attributing such cases to true treatment resistance.

What if the way back to health isn't found in fighting harder… but in reconnecting with nature? After being diagnosed with leukemia and lymphoma, Dean Hall made a decision that left even his doctors shaking their heads. He swam 187 miles of Oregon's longest river. He embraced a practice known as forest bathing. Today, Dean is in remission! Coincidence? Conviction? Or is there more to this story? In this week's episode, Autumn and Dean explore a radically different conversation about healing, purpose, grief, the nervous system, and our relationship with the natural world God created. This conversation may completely change the way you think about striving for health, supporting the body's ability to heal, and God's fingerprints woven throughout creation.

At just 16 years old, Hayden Laufgraven heard the words no teenager expects:"You have leukemia."What followed was hospitalisation, chemotherapy, a bone marrow transplant, remission, relapse, another transplant, months of isolation, and learning how to never give up. In this deeply moving episode of Talking Smack 415, Jamie the Great and I sit down with Hayden to talk about what it's really like to be diagnosed with Acute Myeloid Leukemia (AML) as a teenager, the emotional toll of the diagnosis and surviving cancer, and the often-overlooked reality of PTSD after cancer treatment.Hayden shares his remarkable perspective on resilience, friendship, identity, and why surviving cancer doesn't mean the journey is over.Whether you've experienced cancer yourself, love someone who has, or simply need a reminder of the strength of the human spirit, this conversation will stay with you long after it ends. Hayden is wise beyond his years. In this episode we discuss:What it's like being diagnosed with Acute Myeloid Leukemia (AML) at age 16The signs and symptoms that led to his leukemia diagnosisChemotherapy, remission, relapse, and undergoing two bone marrow transplantsHow donor registries and bone marrow matching workThe physical and emotional impact of cancer treatmentPTSD and trauma after surviving cancerRebuilding strength after months of chemotherapy and isolationThe importance of friendship, family, and community during illnessMental resilience and finding hope through uncertaintyLife after cancer and returning to college, sports, and everyday lifeHayden's honesty, maturity, and optimism offer an extraordinary reminder that resilience isn't about pretending you're fearless—it's about continuing to move forward anyway.Follow Hayden on TikTok: @haydenlaufIf this episode resonates with you...Please subscribe, rate, and review Talking Smack 415. Sharing this episode may help someone navigating cancer, supporting a loved one through treatment, or healing from the invisible emotional scars that often remain after remission.Cancer changes lives—but so does hope.Share this episode with your friends and family who love to laugh.  Subscribe to Talking Smack 415 and leave us a rating and review so more peeps can find us for laughter and friendship to feed your soul!  

Welcome back to the Oncology Brothers podcast! In this episode, we dived into the latest highlights from the EHA 2026 conference, focusing on groundbreaking studies in the leukemia space. Join us as we welcome Dr. Eunice Wang from Roswell Park Comprehensive Cancer Center to discuss three pivotal studies: OPTI-AML: explored the findings on the use of venetoclax in combination with azacitidine for newly diagnosed AML patients, comparing 14-day versus 28-day treatment regimens and their impact on cytopenias and overall outcomes. KOMET-007: promising early data on menin inhibitors, specifically Ziftomenib, in frontline settings for patients with NPM1 and KMT2A rearrangements, and how it may change the landscape of AML treatment. SENTRY: analyzed the combination of ruxolitinib and selinexor for myelofibrosis, discussing its effects on spleen volume reduction and overall survival, as well as the implications of side effects. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o  Follow us on social media: •⁠  ⁠X/Twitter: https://x.com/oncbrothers  •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers  •⁠  Website: https://oncbrothers.com/  Tune in for an insightful discussion on the future of leukemia treatment and the importance of genetic markers in therapy decisions. Don't forget to like, subscribe, and check out our other conference highlights from ASCO and EHA! #EHA2026, #Leukemia, #AML, #Myelofibrosis, #OncologyBrothers  

MY PLUMPUS IS SAFE!!!!!! THE VET USED A TEST THAT WAS STUPID AND DUMB AND GAVE FALSE POSITIVES! And that was the last of my energy I'm dying of exhaustion, but I love y'all —--------------------- Want more 7th Valkyrie? Check out our Patreon to become a Hero of Edara, where you can shape the future of the series, decide on merch drops and incentives, get early access to new episodes, enjoy bonus features and content, and help us hit the major checkpoints on the Path of Heroes!  https://www.patreon.com/7thvalkyrie  

It's Thursday, July 9. Here are today's top stories around Central Indiana. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org and follow us on social media to get local news every day. WFYI News Now is hosted by Barb Anguiano and produced by Zach Bundy. Subscribe wherever you get your podcasts.

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Kirsty Hillier and Marco Ruella on their latest articles published in Blood. For "Predicting Development of Pediatric Chronic Immune Thrombocytopenia at Disease Onset Using a Statistical Risk Model", Dr. Hillier shares the potential benefits of incorporating this new model to enhance the care of the 1 in 4 patients who develop chronic ITP. As an alternative to current guidelines which advise providers to "wait and see", this online model determines patients who are at risk for chronic ITP, allowing for providers to make informed decisions on their continued care. In "Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies", Dr. Ruella explains how the treatment of T-cell neoplasms is limited by a lack of discriminating T-cell antigens that allow for effective antitumor responses while preventing CAR T-cell fratricide. The team found that CD2 was a viable target, especially combined with a novel PD-1:CD2 switch receptor to remedy dysfunction caused by CD2 deletion.  

Which is like a weird space to be in for "might". Ya know? This is one of the weirdest TABTAs of all time. Got some good stuff coming your way though. —--------------------- Want more 7th Valkyrie? Check out our Patreon to become a Hero of Edara, where you can shape the future of the series, decide on merch drops and incentives, get early access to new episodes, enjoy bonus features and content, and help us hit the major checkpoints on the Path of Heroes!  https://www.patreon.com/7thvalkyrie  

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Heinz Zoller and Raul Ribeiro on their latest articles published in Blood. Dr. Zoller discusses "Ferric Carboxymaltose Increases Fracture Risk in Patients and Reduces Bone Formation in Mice with Iron Deficiency Anemia", and how these findings support consideration of alternative IV iron formulations that provide similar efficacy without risk of skeletal complications.  Dr. Ribeiro discusses "A low-versus standard-dose regimen an induction for AML: a multicenter, randomized noninferiority trial" and how the low-dose regimen is associated with fewer toxicities, faster hematologic recovery, and reduced health care costs, suggesting a feasible treatment strategy for resource-limited settings.

In today's episode, we spoke with Courtney D. DiNardo, MD, MSCE, a professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center and an associate member of The University of Texas Graduate School of Biomedical Sciences in Houston.In our exclusive interview, Dr DiNardo discussed the May 2026 FDA approval of decitabine (Dacogen) and cedazuridine (Inqovi) plus venetoclax (Venclexta) in patients with newly diagnosed acute myeloid leukemia (AML). DiNardo outlined numerous important facets of the approval, including its effects on the treatment paradigm, which patients will benefit most, safety considerations with the regimen, and quality of life advantages that have been observed with the combination. Furthermore, she discussed how this approval fits into a larger shift for the AML treatment paradigm and how the AML research field can build upon the approval of this regimen.

Send us Fan MailMorning Prayer (Bread of life; Hungry for The Word; Glorify God Our Life Filter; Leukemia .... ; Praising God) #Jesus #prayer #BreadOfLife #WordOfGod Thank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peaceaimingforjesus.comYouTube Channel https://www.youtube.com/@aimingforjesus5346Instagram https://www.instagram.com/aiming_for_jesus/Threads https://www.threads.com/@aiming_for_jesusX https://x.com/AimingForJesusTik Tok https://www.tiktok.com/@aiming.for.jesus

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Everett Meyer and Olivier Hermine on their latest articles published in volume 147 issue 11 of Blood. Dr. Everett Meyer discusses "Orca-T vs allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial" which demonstrated that Orca-T showed superior chronic GVHD–free survival compared to the control arm (78.0% vs 38.4%, P < .001) and lower nonrelapse mortality (3.4% vs 13.2%, P = .03). Dr. Olivier Hermine shares insights from "VEXAS anemia is a mosaic erythroblastopenia" which proposes that VEXAS syndrome–associated anemia should be considered as a mosaic erythroblastopenia, in which the severity of anemia is influenced by the quality and quantity of the UBA1–wild-type compartment.

Jeff Granville, Founder and President of Mindful Presents is a Mindfulness Practitioner. Coherence Counselor. Spiritual Advisor, and Trauma Specialist. He is endorsed by Bruce H. Lipton, Ph.D., and Bruce Cryer, former CEO, HeartMath. Jeff served for 4 years as a member of the Family advisory council at Seattle Children's Hospital and trained as a first responder in the Parent Support team. He served on the nurse training, anesthesiologist training, Root Cause Analysis and Hospital Acquired Condition panels. As well as consultant to the clinical efficacy department.Jeff is a 5th generation inhabitant of the San Juan Islands, growing up on and around the waters or the Pacific Northwest. And is a father of 8 and Grandfather of 10 beautiful children.After his youngest son Makoy was diagnosed with a rare form of T-cell Leukemia, Jeff became a Mindfulness Practitioner and formed the nonprofit Mindful Presents to bring the gift of mindfulness, coherence and controlled breathing to pediatric patients, families and care providers.Since then, Jeff has opened up his services to the general public and specializes in Coherence Breathing, STIR; Somatic Trauma Imprint Release and aspect reintegration.Mindfulpresents.orgjeff@mindfulpresents.orghttps://www.facebook.com/MindfulPresents.orghttps://www.youtube.com/@jeffgranville4790360-941-7005More about Liz:Work- https://www.raisethevibewithliz.com/Radio Show- https://www.voiceofvashon.org/raise-the-vibePodcast- https://www.buzzsprout.com/958816Facebook- https://www.facebook.com/raisethevibewithlizInstagram- https://www.instagram.com/raisethevibewithliz/*** Support the show! https://www.buzzsprout.com/958816/supporthttps://paypal.me/LisbethPeterson?country.x=US&locale.x=en_USJoin The Community!

Adriana Luna and her fiancé, Anthony Lerma, weren’t expecting any babies at all when they discovered they were going to have four. AND The Massachusetts teen completed a marathon at a hospital despite battling leukemia, and the whole medical facility had his back. To see videos and photos referenced in this episode, visit GodUpdates! https://www.godtube.com/blog/birth-to-quadruplets.html https://www.godtube.com/blog/teen-completes-marathon-at-hospital.html Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

In this episode, Blood editor Dr. Laura Michaelis interviews Drs. Nigel Russell and Uwe Platzbecker on their articles published in volume 147 issue 10 of Blood. Dr. Russell discuses "CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non–adverse-risk AML: the NCRI AML18 trial" where a large randomized trial demonstrated that DA-GO2 provided greater overall survival as compared to CPX-351, and that further studies should compare DA-GO2 to lower-intensity venetoclax-based regimens. Dr. Platzbecker shares insights from the first prospective study to evaluate the clinical impact of early therapeutic intervention for MRD in "Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial" demonstrating potential therapies for patients to achieve and maintain remission.

In this episode, we review the high-yield topic of⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hairy Cell Leukemia (HCL)⁠⁠ ⁠⁠from the Oncology section.Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets

During Alisha Harper's pregnancy, she was told that there was a 60 percent chance that her son would be born with Down Syndrome. That statement turned out to be a correct one as Chase was born in December of 2016 with this illness and by the time Chase was 4 years old, Alisha saw that his Down Syndrome was manageable. One month after feeling as good as possible about how Chase was doing, he developed a body rash which turned out to be a symptom of Acute Lymphoblastic Leukemia. Despite having this 1-2 punch thrown at him, Chase is doing well as he is now 9 years old and living his best life possible. 

In this week's episode, Blood editor Dr. Philippe Armand interviews Drs. Manali Kamdar and Nancy L. Bartlett on their latest review article published in Blood titled “From breakthroughs to blueprints: evolving evidence and future directions in relapsed and refractory large B-cell lymphoma”. They discuss the how the advent of chimeric antigen receptor T cells, antibody-drug conjugates, and bispecific antibodies all show major increases in efficacy over legacy chemotherapy-based regimens. They also share their insights on how to transform treatment paradigms in light of these breakthroughs.

In this Review series episode, Blood associate editor Dr. Diane Krause interviews contributing authors from the Review Series on Clonal tracking in Hematopoiesis published in volume 147 issue 23 of Blood. Dr. Alejo E. Rodriguez-Fraticelli speaks to the development of his paper, "Clonal tracing of blood stem cells across mouse and human lifespans”, which provides a detailed overview of the experimental approaches that make clonal analysis possible, and which approaches are most appropriate to use to address specific questions. Dr. Shalin H. Naik speaks about how different clonal tracking approaches have been used to address the central question of clonal fate specification of stem and progenitor cells to specific lineages in “The evolution of hematopoietic models through a clonal lens”. Finally, Dr. Federico Gaiti speaks about “Methylation-based lineage tracing in cancer”, which takes these ideas into the context of cancer, focusing on how DNA methylation can be used to reconstruct clonal relationships.  

On Saturday night, folks will gather at the Sagamore Pendry to celebrate the Visionary of The Year for Blood Cancer United, which you might know was the Leukemia and Lymphoma Society. Former MLB outfielder and Towson alum Casper Wells is pitching in and batting cleanup in trying to raise funds and awareness and visits with Nestor here for some current Orioles chatter and ways you can help cancer patients. The post Former MLBer Casper Wells returns to talk blood cancer and Orioles finding bats and more runs first appeared on Baltimore Positive WNST.

What if your body already has everything it needs to heal and unresolved trauma is the only thing standing in the way?In this episode of What Happens in Vagus, Dr. Stephanie Canestraro sits down with Peter McLaughlin, a certified hypnotherapist who put his chronic lymphocytic leukemia into remission in 2003, without chemotherapy. Peter's journey began in the wreckage of a life running on pure adrenaline: a demanding Wall Street career, a two-hour daily commute, three young children, and an office one block from Ground Zero on September 11th. When his body finally gave out, his leukemia diagnosis became the catalyst that set him on a path toward subconscious healing, hypnotherapy, and a complete understanding of the mind-body connection.Together, Peter and Dr. Stephanie explore one of the most overlooked truths in chronic illness: that emotional trauma, including small, seemingly insignificant moments from childhood, gets stored in the subconscious mind and continues to drive the body's stress response for decades. Because the subconscious has no concept of time, a humiliating moment in third grade or a cry left unanswered in a crib can still be activating a fight-or-flight response in your body today. This chronic activation of the autonomic nervous system suppresses immunity, disrupts hormones, stalls digestion, and creates the environment in which disease takes root.Dr. Stephanie also shares her own healing journey from a Lyme disease and Bartonella infection that attacked her nervous system and went undiagnosed for over a decade, to the functional medicine interventions, precious metal IVs, and reconnection with her body's inner wisdom that finally brought her back. Together they connect the dots between nervous system dysregulation, frequency medicine, and the extraordinary capacity of the human body to heal when given the right tools.✦ In this episode:• How chronic stress and emotional trauma directly contribute to serious illness• Why childhood events your conscious mind has "forgotten" are still running your nervous system• What hypnotherapy actually does and how it clears emotional toxins from the subconscious• Why you cannot heal in fight-or-flight mode and how to shift into rest-and-digest• How cortisol signals your body to hold onto fat• 432 Hz healing music, binaural beats, and frequencies that regulate the nervous system• Applied kinesiology, muscle testing, and pendulum work as tools for inner wisdom• Peter's work with professional athletes and how childhood trauma shows up on the field• Precious metals (gold, silver, platinum) and their role in healing chronic infection• The placebo effect as proof of the mind's power to heal the body✦ Find Peter McLaughlin:Website & healing tracks: blueskyhypnosis.comYouTube: @blueskyhypnosis✦ About Dr. Stephanie Canestraro:Dr. Stephanie is a chiropractor, functional medicine practitioner, and chronic illness survivor. Her practice and this podcast are rooted in one belief: that the body is designed to heal, and that the vagus nerve is the master key to making that happen.Let us know your thoughts on this episode hereFor any further information, feel free to email us at info@vagusclinic.com.  Our team is happy to help.  We offer 20-minute complimentary health calls, and you can sign up for one here.

Message us!In this episode of Whitley Penn Talks, host Emily Landry is joined by Dr. Paul Bowman, longtime pediatric oncologist and co-chair of Leukemia Texas, who shares clear and hopeful insights on what leukemia is and how far treatment for the disease has come. Alongside him, Ashley Oviedo opens up about her daughter, Perry's, diagnosis, offering an honest and emotional look at the fear, uncertainty, and strength that define a family's journey through cancer.Together, they highlight the critical role organizations like Leukemia Texas play in supporting families medically, financially, and emotionally through their most challenging times. From the first signs of illness to the importance of accepting help and holding onto hope, this conversation is a reminder that no one should fight cancer alone.Fill out this form to have new episodes sent right to your inbox! Follow Whitley Penn on LinkedIn, Instagram, Facebook, and X for more industry insights and thought leadership!

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Johnny Mahlangu and Joseph Rocco on their articles published in volume 147 issue 9 of Blood.  Dr. Mahlangu discusses study details and next steps from "Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial" which shows that bleeding was reduced by 93% with subcutaneous marstacimab. Dr. Rocco shares the development behind "CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis", and the insights gained from measuring a new surrogate marker of IFN-γ activity predicting severity and mortality.

Yale Cancer Center Director Dr. Eric Winer speaks with Dr. Max Stahl about how much is now known on the biology of leukemia in some patients, rare disease sub-types and targeting with specific therapies. Yale Cancer Center Visit: https://medicine.yale.edu/cancer/ Email: canceranswers@yale.edu Call 203-785-4095

 In this episode, Blood deputy editor Dr. Helen Heslop interviews contributing  authors from the Blood review series on hemophagocytic lymphohistiocytosis. Drs. Nancy Berliner and Joanne Hsu join to provide insight on their paper, “Hemophagocytic lymphohistiocytosis in adults” discussing the importance of prompt diagnosis and treatment in this high-mortality disorder, and highlight emerging agents designed to modulate disease progression. Drs. Carl Allen and Bethany Verkamp reimagine diagnostic criteria through a threshold model in “Pediatric hemophagocytic lyphohistiocytosis: current conceptualization, diagnosis, and treatment”, in order to provide individualized therapies with the goal of addressing the combined influence of genetic susceptibility and environmental triggers.

Learn More about Peter at: https://www.linkedin.com/in/petertmclaughlin/ and his work at : https://blueskyhypnosis.com Follow him on Social Media: Twitter: https://x.com/PetMcLaughlin IG: https://www.instagram.com/thepetermclaughlin/ YT: https://www.youtube.com/@BlueSkyHypnosis Show Notes   

Dr. Robert Soiffer took an interest in medicine at an early age when he played a physician in his first-grade play.  Today, he is a leading physician, researcher, and teacher at Dana-Farber Cancer Institute, a world leader in oncology.  In this episode, Dr. Soiffer describes the incredible pace of change in the field of cancer research and treatment and the detection tools and cures that are right around the corner.  He also reflects on how he maintains a positive and optimistic outlook despite the many times he's forced to deliver terrible news to patients and families.  While he tries hard not to bring these tough times home with him, he also stresses the importance of keeping his humanity and treating his patients and their families as people, not just statistics.     Chapters:  02:29 Dana-Farber's Special Mission  Dr. Soiffer discusses what makes Dana-Farber Cancer Institute unique, emphasizing its focus on cancer patients and the common purpose among all staff.   05:50 Evolution of Cancer Treatment  This segment details the seismic shift in cancer treatment over the past 40 years, from nonspecific chemotherapy to targeted therapies focusing on specific mutations.   10:25 Bone Marrow Transplants and Graft vs. Leukemia  Dr. Soiffer delves into the history of bone marrow transplants, highlighting the Nobel Prize-winning work of E. Donald Thomas and the intriguing concept of graft versus leukemia effect.   15:02 The Role of Medical Education and Mentoring  This chapter emphasizes the critical role of medical education and mentoring in shaping the future of medicine, drawing from Dr. Soiffer's experience as chief medical resident and mentor. He discusses the mutual learning process between experienced physicians and younger generations, and the importance of continuous learning.  19:50 Personal Impact of Oncology Work  Dr. Soiffer reflects on the emotional challenges of his work, balancing optimism with realism and honesty while treating patients facing life-threatening situations. He discusses the difficulty of compartmentalizing emotions and the importance of maintaining humanity and connection with patients and their families, even when outcomes are not positive.  24:57 The Value of Clinical Trials  This chapter explains the critical role of clinical trials in advancing cancer treatment, from early-stage phase I trials to comparative studies. Dr. Soiffer describes patients participating in these trials as brave pioneers, highlighting how targeted, immune, and cellular therapies would not exist without their contributions.  28:39 Global Collaboration in Medicine  Dr. Soiffer discusses the extensive global collaboration in medical and scientific fields, emphasizing the shared mission to develop therapies for suffering patients.   35:33 Future of Cancer Treatment and Prevention  Looking ahead, Dr. Soiffer predicts less toxic and more precise cancer treatments with improved therapeutic ratios, focusing on overcoming resistance and early detection. He discusses the potential of preventing progression to full-blown malignancy through early intervention and the growing understanding of germline predispositions to cancer.  41:26 Conclusion and Call to Optimism  The episode concludes with Bill Burke thanking Dr. Soiffer for his time and invaluable insights, highlighting the rapid pace of change and innovation in cancer research. He also expresses hope and optimism for the future of cancer care. 

I am very excited to launch a very special series for Jake's Take with Jacob Elyachar Podcast. May is Jewish American Heritage Month (JAHM), which annually celebrates the history, culture, and contributions of Jewish Americans to the United States.  There are no words to describe how ecstatic I am to welcome back Ethan Zohn for a third time! Ethan became a household name when he first appeared on Survivor: Africa, the third season of the legendary US reality TV competition. He won seven challenges and the title of “Sole Survivor.” He appeared on Survivor: All-Stars, where he won four challenges but lasted only 21 days, and returned to compete in the milestone season Survivor: Winners at War, where he only won one challenge and lasted 35 days.  Since Survivor, Ethan has become an influential social entrepreneur. With a portion of his Survivor: Africa winnings, he co-founded Grassroot Soccer (GRS). GRS is an adolescent health organization that harnesses the power of soccer to provide young people with the essential information, services, and mentorship they need to lead healthier lives. Since its inception, GRS has expanded to 60 countries in Africa and worldwide, has graduated 13 million youth, and has worked with scores of public—and private-sector partners.  He also raised his voice to fight cancer.  Cancer-free since 2012, Ethan Zohn has been a voice for fighters, survivors, and caregivers of all ages, even chronicling the gritty details of his entire cancer experience for People Magazine. While undergoing treatment, he ran and finished the New York City and Boston marathons to help spread messages of hope and resilience to the world.  Ethan is a champion for investment in new medical research and technology. He is an advisor to numerous hospitals and foundations, such as Cancer Buddy, the Leukemia and Lymphoma Society, and Memorial Sloan Kettering.  As demonstrated by his charitable work, tzedakah, and community involvement, Ethan believes that Jewish values can achieve a better and healthier world. His inspiration to help heal the world stems from being taught at an early age the importance of community, a connection to the Jewish faith, and the preservation of Israel.  Ethan shares his deep bond to Judaism, his connection to the Jewish community, and his relationship with Israel by partnering with Jewish organizations that do critical work worldwide, such as BBYO, the Jewish National Fund, and Maccabi USA.  On this edition of The Jake's Take with Jacob Elyachar Podcast, Ethan Zohn gave his take on Survivor 50, previews Grassroot Soccer's 25th anniversary, and how Grassroot Soccer is going to play a role with the World Cup coming to North America.Become a supporter of this podcast: https://www.spreaker.com/podcast/jake-s-take-with-jacob-elyachar--4112003/support.

Learn essential Medical Spanish terms related to leukemia hospitalization, transfusions, chemotherapy, and the crucial role played by family. The post Leukemia Hospitalization | Medical Spanish from Guatemala appeared first on Doc Molly.

TODAY ON THE ROBERT SCOTT BELL SHOW: Jonathan Emord, Whole Foods Pulls Homeopathics, Government Cannot Heal Us, Fauci Email Manager Charged, Gore's New Ice Age, Iowa Vaccine Ban Bill, Florida Vax Mandates, Chemicals in New Babies Blood, Childhood Leukemia Link, Autism Committee Meets, Castor Equi, and MORE! https://robertscottbell.com/jonathan-emord-whole-foods-pulls-homeopathics-government-cannot-heal-us-fauci-email-manager-charged-gores-new-ice-age-iowa-forced-vaccine-ban-bill-florida-vaccine-mandates-chemicals-in-new-ba/ Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

In this episode, we review the high-yield topic of ⁠ ⁠⁠Hairy Cell Leukemia (HCL)⁠⁠⁠ from the Oncology section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

Navigate the challenges of an AMA discharge in Spanish while following Ingrid's family's leukemia journey and their decisions. The post Facing Leukemia | An AMA Discharge in Spanish – A Patient’s Journey appeared first on Doc Molly.

What if the reason you feel stuck has nothing to do with willpower? Hypnotherapist Peter McLaughlin breaks down the truth about the subconscious mind and how it impacts your habits, relationships, and healing. After being diagnosed with Leukemia and Lyme disease, he was told he had 10 years to live. So Peter began exploring the mind-body connection, and what he discovered not only changed his life, but became his life’s work.

"God doesn't always remove the suffering—He enters into it with us.” In this first half of our conversation, Tom and Heather Snyir share the story of their daughter, Katie Rae—a creative, joyful teenager who made everyone around her feel like they were her best friend.Katie was diagnosed with leukemia at just four years old.  Tom and Heather share what it was like to navigate months of treatment, a bone marrow transplant, and the gift of more than a decade of remission.Then, as a teenager, Katie was diagnosed with glioblastoma, an aggressive and deadly form of brain cancer. In this episode, Tom and Heather begin sharing what that journey looked like for their family and how they walked through those difficult days together until Katie went to Heaven.Throughout this conversation, you'll hear how their faith was stretched and sustained—not through easy answers, but through God's presence in the middle of uncertainty.Resources & Mentions Tom Snyir's book: Branches of Grace: Devotions from the Front Lines of Faith - Available HERE.  Coming NextIn next week's episode, Tom and Heather share what life has looked like since Katie went to Heaven. We talk about grief in everyday life, how people respond to loss, and Tom shares more of his personal journey through PTSD, depression, and finding hope.I would love to hear your thoughts on the show. Click here to send me a message! (Though I read every message, I am unable to respond through this format.) ** IMPORTANT** - All views expressed by guests on this podcast are theirs alone, and may not represent the Statement of Faith and Statement of Beliefs of the While We're Waiting ministry.  We'd love for you to connect with us here at While We're Waiting! Click HERE to visit our website and learn about our free While We're Waiting Weekends for bereaved parentsClick HERE to learn more about our network of While We're Waiting support groups all across the country. Click HERE to subscribe to our YouTube channelClick HERE to follow our public Facebook pageClick HERE to follow us on Instagram Click HERE to follow us on Twitter Click HERE to make a tax-deductible donation to the While We're Waiting ministryContact Jill by email at:  jill@whilewerewaiting.org